Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors
about
Genetic testing in asymptomatic minors: background considerations towards ESHG RecommendationsNewborn screening for cystic fibrosis: a lesson in public health disparitiesReturn of individual research results and incidental findings: facing the challenges of translational scienceACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingGenetics and cardiovascular disease: a policy statement from the American Heart Association.Genetic testing of children for predisposition to mood disorders: anticipating the clinical issuesEffects of undergoing multiplex genetic susceptibility testing on parent attitudes towards testing their children.Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Can children and young people consent to be tested for adult onset genetic disorders?Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.Genetic testing of newborns for type 1 diabetes susceptibility: a prospective cohort study on effects on maternal mental health.Effects of hypothetical type 2 diabetes genetic testing on parents' efforts to prevent diabetes in children.Carrier detection in childhood: a need for policy reform.Traditional roles in a non-traditional setting: genetic counseling in precision oncologyReturn of genomic results to research participants: the floor, the ceiling, and the choices in between.Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when and howGenetic counseling for isolated GnRH deficiency.Genetic counselling for schizophrenia in the era of molecular genetics.Medical genetics: 3. An approach to the adult with a genetic disorder.Controversies in communication of genetic screening results for cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida).Clinic-based infant screening for duchenne muscular dystrophy: a feasibility study.Comprehensive carrier screening and molecular diagnostic testing for recessive childhood diseases.Addressing the ethical challenges in genetic testing and sequencing of children.Normal iron metabolism and the pathophysiology of iron overload disordersResearch issues in genetic testing of adolescents for obesity.Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.Parental attitudes, beliefs, and perceptions about genetic testing for FAP and colorectal cancer surveillance in minors.Emerging issues in public health genomics.Attitudes of African-American parents about biobank participation and return of results for themselves and their childrenCharcot-Marie-Tooth disease subtypes and genetic testing strategiesDeep sequencing of patient genomes for disease diagnosis: when will it become routine?Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units."We don't know her history, her background": adoptive parents' perspectives on whole genome sequencing resultsRapid pulsed whole genome sequencing for comprehensive acute diagnostics of inborn errors of metabolism.Refusing to provide a prenatal test: can it ever be ethical?Best practice guidelines for the molecular genetic diagnosis of Type 1 (HFE-related) hereditary haemochromatosisAre the kids really all right? Direct-to-consumer genetic testing in children: are company policies clashing with professional norms?Commentary: Children and predictive genomic testing: disease prevention, research protection, and our future.Parental attitudes toward ethical and social issues surrounding the expansion of newborn screening using new technologiesStrategy for genetic testing in Charcot-Marie-disease.
P2860
Q24599256-8302F769-55E3-48C5-A193-E8F543BAE41FQ24651326-B568764A-E570-437C-B5B5-4A948EAE23A0Q27026989-E63D97F2-6DCE-4AFB-BF0F-08A55E887E13Q29616235-E203F3D3-618B-474F-93F1-F771B2BBE4EEQ30418104-0A3E2C12-C9D4-4344-8CFF-F956DFC4A5E9Q30583355-6A1D7FF5-223B-48C6-89E0-0D79B6DA16DBQ33560771-93961CB7-E9AF-471C-B944-417B3C6E450BQ33564013-2A392CDA-87D2-4103-A045-1242C26946BEQ33594848-96C62FC9-913B-49E9-8713-22F0462ED1C4Q33600262-5FC2E7D4-0C59-4717-BB7F-726E2603E757Q33632761-51E0449A-E8A2-43E2-94D8-74796BAC5BF8Q33672532-F49135F2-29F7-4A2E-9001-76928FE4368AQ33865770-A53AA28B-4F61-4047-BB08-43078E6FFF59Q33894053-F093E061-FDF8-42B0-835C-F1DBB48CFDA1Q34000877-2ED3AB88-3D2F-4E36-A68A-8D5A728BB973Q34167625-0D345FDC-2C65-4B12-BEC9-46C414B60EC2Q34191671-5EAD1477-0D6A-4446-8646-9AEF4DB321F9Q34203058-71D3FBA2-B66A-46B9-AA82-568826E36C9BQ34289457-E3EA3EF2-723B-4801-A191-A1AADC99B909Q34351351-41A1C1A9-4ADD-4788-9B69-E7D7177912CDQ34367197-01DB7803-2A0C-4DA1-B401-1DF577A65F5FQ34370597-7B3FEFBB-2CA0-40DF-A664-A5EEBA011A05Q34408150-B09D57E0-161C-4D88-8023-4A9855A26273Q34427279-C1FA3FEA-3F75-4679-8D6F-8613562D2423Q34451971-CBF89E27-8972-454C-B96B-39FF5EF026E0Q34483451-AD536617-2981-43C8-8DA4-6700A96B1F64Q34489219-E4B4AE5D-E229-458E-8481-C54215CDE981Q34496940-651C6814-520D-449A-A29D-FF5577B378A8Q34663288-EEA20BDE-107E-428B-8BC8-F48C92F52837Q34681666-9C6FB315-565B-42B9-BE88-95E7CB506E2CQ34691675-EB3893E4-32AA-4A4D-922F-E7E8E2B1A023Q34820081-2F38EBC7-EA75-4290-A9E0-3F04AEC25718Q34921696-EC124A1C-5142-46D5-A444-A2EB157A41AEQ34987873-0A512E0C-280A-4D93-94B1-519F506F6AE4Q35148131-5E7B8A64-DAE1-49C3-B9A0-443175FD6FB9Q35199292-CAF6E9F3-EF35-4139-884D-82D2C8D3B781Q35406266-296FE631-4F8F-4726-9597-6F8ADBF987FDQ35423118-7EDD3BC6-23C6-4779-B89D-24DB11DD6901Q35546287-D8983D70-1195-478E-81FE-A6A8F0FE5765Q35607487-E1CF0C5E-52DB-470F-8208-8C20F9252175
P2860
Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors
description
article
@en
im November 1995 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 1995
@uk
name
Points to consider: ethical, l ...... al Genetics Board of Directors
@en
Points to consider: ethical, l ...... al Genetics Board of Directors
@nl
type
label
Points to consider: ethical, l ...... al Genetics Board of Directors
@en
Points to consider: ethical, l ...... al Genetics Board of Directors
@nl
prefLabel
Points to consider: ethical, l ...... al Genetics Board of Directors
@en
Points to consider: ethical, l ...... al Genetics Board of Directors
@nl
P2860
P921
P1476
Points to consider: ethical, l ...... al Genetics Board of Directors
@en
P2860
P304
P407
P577
1995-11-01T00:00:00Z